Brief: Brii Biosciences Says Joincare To Obtain Exclusive License From Unit
04/07/2025 02:09
July 4 (Reuters) - Brii Biosciences Ltd 2137.HK: JOINCARE TO OBTAIN EXCLUSIVE LICENSE FROM UNIT FOR COMMERCIALIZATION, OTHERS, OF BRII-693 IN MAINLAND CHINA, HONG KONG, MACAU & TAIWAN Further company coverage: 2137.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR